Biochemistry and pathophysiology of intravascular and intracellular lipolysis

Genes and Development

Volumn 27, Issue 5, 2013, Pages 459-484

  Young, Stephen G ^a   Zechner, Rudolf ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adipose triglyceride lipase; CGI 58; GPIHBP1; Hormonesensitive lipase; Lipolysis; Lipoprotein lipase; Monoglyceride lipase

Indexed keywords

FATTY ACID; GLYCEROL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; LIPOPROTEIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; CACHEXIA; CANCER CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME MECHANISM; GENE; GENE MUTATION; HUMAN; HYDROLYSIS; HYPERLIPOPROTEINEMIA TYPE 1; INTRACELLULAR LIPOLYSIS; INTRAVASCULAR LIPOLYSIS; LIPID METABOLISM; LIPIDOSIS; LIPOLYSIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; REVIEW; WHITE ADIPOSE TISSUE;

ANIMALS; BLOOD VESSELS; COMMUNICABLE DISEASES; ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SPACE; LIPASE; LIPOLYSIS; LIPOPROTEIN LIPASE; NEOPLASMS; PROTEIN BINDING;

EID: 84874900503     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.209296.112     Document Type: Review

References (332)

1. Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, Isaksson B, Permert J, Arner P. (2007). Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67: 5531-5537.
2. Ahmadian M, Abbott MJ, Tang T, Hudak CS, Kim Y, Bruss M, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, et al. (2012). Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab 13: 739-748.
3. Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H. (2007). Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve 36: 856-859.
4. Albert J, Horenstein R, Yerges-Armstrong L, Sreenivasan U, Snitker S, O'Connell J, McLenithan JC, Shuldiner A, Sztalryd C, Damcott C. (2011). A human hormone sensitive lipase (HSL) knockout: Window into mechanisms of dyslipidemia and diabetes. 61st Annual Meeting of the American Society of Human Genetics, Program No. 81. http://www.ichg2011.org/cgi-bin/showdetail.pl?absno=11253.
5. Andreo U, Maillard P, Kalinina O, Walic M, Meurs E, Martinot M, Marcellin P, Budkowska A. (2007). Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol 9: 2445-2456.
6. Arner P. (2005). Human fat cell lipolysis: Biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19: 471-482.
7. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. (2006). Steatosis in chronic hepatitis C: Why does it really matter? Gut 55: 123-130.
8. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. (2006). Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3: e22.
9. Balser WA. (1882). Ueber Fettnekrose, eine zuweilen tödtliche Krankheit des Menschen. Virchows Arch 90: 520-535.
10. Banerji S, Flieger A. (2004). Patatin-like proteins: A new family of lipolytic enzymes present in bacteria? Microbiology 150: 522-525.
11. Bartz R, Zehmer JK, Zhu M, Chen Y, Serrero G, Zhao Y, Liu P. (2007). Dynamic activity of lipid droplets: Protein phosphorylation and GTP-mediated protein translocation. J Proteome Res 6: 3256-3265.
12. Baulande S, Lasnier F, Lucas M, Pairault J. (2001). Adiponutrin, a transmembrane protein corresponding to a novel dietary-and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem276: 33336-33344.
13. Beigneux AP, Davies B, Gin P, Weinstein MM, Farber E, Qiao X, Peale P, Bunting S, Walzem RL, Wong JS, et al. (2007). Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5: 279-291.
14. Beigneux AP, Gin P, Davies BS, Weinstein MM, Bensadoun A, Ryan RO, Fong LG, Young SG. (2008). Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase. J Lipid Res 49: 1312-1321.
15. Beigneux AP, Davies BS, Bensadoun A, Fong LG, Young SG. (2009a). GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J Lipid Res 50: S57-S62.
16. Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BS, Kuivenhoven JA, et al. (2009b). Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 29: 956-962.
17. Beigneux AP, Gin P, Davies BSJ, Weinstein MM, Bensadoun A, Fong LG, Young SG. (2009c). Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase. J Biol Chem284: 30240-30247.
18. Beigneux AP, Davies BS, Tat S, Chen J, Gin P, Voss CV, Weinstein MM, Bensadoun A, Pullinger CR, Fong LG, et al. (2011). Assessing the role of the glycosylphosphatidylinositolanchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase. J Biol Chem 286: 19735-19743.
19. Bell M, Wang H, Chen H, McLenithan JC, Gong DW, Yang RZ, Yu D, Fried SK, Quon MJ, Londos C, et al. (2008). Consequences of lipid droplet coat protein downregulation in liver cells: Abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57: 2037-2045.
20. Beller M, Sztalryd C, Southall N, Bell M, Jackle H, Auld DS, Oliver B. (2008). COPI complex is a regulator of lipid homeostasis. PLoS Biol 6: e292.
21. Bengtsson G, Olivecrona T. (1979). Apolipoprotein CII enhances hydrolysis of monoglycerides by lipoprotein lipase, but the effect is abolished by fatty acids. FEBS Lett 106: 345-348.
22. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagné SE, Hayden M. (1996). Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 335: 848-854.
23. Ben-Zeev O, Doolittle MH, Singh N, Chang CH, Schotz MC. (1990). Synthesis and regulation of lipoprotein lipase in the hippocampus. J Lipid Res 31: 1307-1313.
24. Ben-Zeev O, Stahnke G, Liu G, Davis RC, Doolittle MH. (1994). Lipoprotein lipase and hepatic lipase: The role of asparaginelinked glycosylation in the expression of a functional enzyme. J Lipid Res 35: 1511-1523.
25. Ben-Zeev O, Hosseini M, Lai CM, Ehrhardt N, Wong H, Cefalu AB, Noto D, Averna MR, Doolittle MH, Peterfy M. (2010). Lipase maturation factor 1 is required for endothelial lipase activity. J Lipid Res 52: 1162-1169.
26. Bergman EN, Havel RJ, Wolfe BM, Bøhmer T. (1971). Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J Clin Invest 50: 1831-1839.
27. Bernard C. (1856). Mémoire sur le pancréas et sur la role du suc pancréatique dans les phénomèmes digestifs particuliè rement dans la digestion des matiè res grasses neutres. Nabu Press, BiblioBazaar, Charleston, SC.
28. Bertrand T, Auge F, Houtmann J, Rak A, Vallee F, Mikol V, Berne PF, Michot N, Cheuret D, Hoornaert C, et al. (2010). Structural basis for human monoglyceride lipase inhibition. J Mol Biol 396: 663-673.
29. Bessesen DH, Richards CL, Etienne J, Goers JW, Eckel RH. (1993). Spinal cord of the rat contains more lipoprotein lipase than other brain regions. J Lipid Res 34: 229-238.
30. Boni LT, Rando RR. (1985). The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols. J Biol Chem260: 10819-10825.
31. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. (2011). Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60: 1458-1466.
32. Boulant S, Targett-Adams P, McLauchlan J. (2007). Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88: 2204-2213.
33. Brand K, Dugi KA, Brunzell JD, Nevin DN, Santamarina-Fojo S. (1996). A novel A/G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res 37: 1213-1223.
34. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. (1978). Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298: 1265-1273.
35. Breedveld B, Schoonderwoerd K, Verhoeven AJM, Willemsen R, Jansen H. (1997). Hepatic lipase is localized at the parenchymal cell microvilli in rat liver. Biochem J 321: 425-430.
36. Brown JM, Betters JL, Lord C, Ma Y, Han X, Yang K, Alger HM, Melchior J, Sawyer J, Shah R, et al. (2010). CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res 51: 3306-3315.
37. Brown RJ, LagorWR, Sankaranaravanan S, Yasuda T, Quertermous T, Rothblat GH, Rader DJ. (2010). Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ Res 107: 357-364.
38. Brunzell JD, Deeb SS. (2001). Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In The metabolic and molecular bases of inherited disease (ed. Scriver CR, et al.), pp. 2789-2816. McGraw-Hill, New York.
39. Busca R, Pujana MA, Pognonec P, Auwerx J, Deeb SS, Reina M, Vilaro S. (1995). Absence of N-glycosylation at asparagine 43 in human lipoprotein lipase induces its accumulation in the rough endoplasmic reticulum and alters this cellular compartment. J Lipid Res 36: 939-951.
40. Carter SA, Foster NA, Scarpini CG, Chattopadhyay A, Pett MR, Roberts I, Coleman N. (2012). Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the noncatalytic C terminus. Br J Cancer 107: 739-747.
41. Cefalu AB, Noto D, ArpiML, Yin F, Spina R, Hilden H, Barbagallo CM, Carroccio A, Tarugi P, Squatrito S, et al. (2009). Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J Clin EndocrinolMetab 94: 4584-4590.
42. Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G. (1975). Neutral-lipid storage disease: A new disorder of lipid metabolism. BMJ 1: 553-555.
43. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, Piesla MJ, Zhang MY, Bingham B, Uveges A, et al. (2010). Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol 78: 996-1003.
44. Chang S-F, Reich B, Brunzell JD, Will H. (1998). Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2. J Lipid Res 39: 2350-2359.
45. Charriere S, Peretti N, Bernard S, Di Filippo M, Sassolas A, Merlin M, Delay M, Debard C, Lefai E, Lachaux A, et al. (2011). GPIHBP1 C89F neomutation and hydrophobic Cterminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. J Clin Endocrinol Metab 96: E1675-E1679.
46. Cheung W, Gill M, Esposito A, Kaminski CF, Courousse N, Chwetzoff S, Trugnan G, Keshavan N, Lever A, Desselberger U. (2010). Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84: 6782-6798.
47. Chon SH, Douglass JD, Zhou YX, Malik N, Dixon JL, Brinker A, Quadro L, Storch J. (2012). Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity. PLoS ONE 7: e43962.
48. Chotivanich K, Udomsangpetch R, Suwanarusk R, Pukrittayakamee S, Wilairatana P, Beeson JG, Day NP, White NJ. (2012). Plasmodium vivax adherence to placental glycosaminoglycans. PLoS ONE 7: e34509.
49. Chung C, Doll JA, Gattu AK, Shugrue C, Cornwell M, Fitchev P, Crawford SE. (2008). Anti-angiogenic pigment epitheliumderived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol 48: 471-478.
50. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. (2005). Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347-2355.
51. Cipriani V, Leung HT, Plagnol V, Bunce C, Khan JC, Shahid H, Moore AT, Harding SP, Bishop PN, Hayward C et al. (2012). Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet 21: 4138-4150.
52. Coca-Prieto I, Kroupa O, Gonzalez-Santos P, Magne J, Olivecrona G, Ehrenborg E, Valdivielso P. (2011). Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: Identification of a novel GPIHBP1 mutation. J InternMed 270: 224-228.
53. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. (2008). Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci 105: 9379-9384.
54. Cohen JC. (2003). Endothelial lipase: Direct evidence for a role in HDL metabolism. J Clin Invest 111: 318-321.
55. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. (1994). Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94: 2377-2384.
56. Cohen JC, Vega GL, Grundy SM. (1999). Hepatic lipase: New insights from genetic and metabolic studies. Curr Opin Lipidol 10: 259-267.
57. Connelly PW. (1999). The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta 286: 243-255.
58. Connelly PW, Hegele RA. (1998). Hepatic lipase deficiency. Crit Rev Clin Lab Sci 35: 547-572.
59. Connelly PW, Maguire GF, Little JA. (1987). Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest 80: 1597-1606.
60. Cox DW, Wills DE, Quan F, Ray PN. (1988). A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto). J Med Genet 25: 649-652.
61. Crecchio C, Capurso A, Pepe G. (1990). Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari). Biochem Biophys Res Commun 168: 1118-1127.
62. Cryer A. (1989). The role of the endothelium in myocardial lipoprotein dynamics. Mol Cell Biochem 88: 7-15.
63. Dalrymple N, Mackow ER. (2011). Productive dengue virus infection of human endothelial cells is directed by heparan sulfatecontaining proteoglycan receptors. J Virol 85: 9478-9485.
64. Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, et al. (2011). Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333: 233-238.
65. Datta S, Luo C-C, Li W-H, VanTuinen P, Ledbetter DH, Brown MA, Chen S-H, Liu S-W, Chan L. (1988). Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem 263: 1107-1110.
66. Davies BSJ, Beigneux AP, Barnes RH II, Tu Y, Gin P, Weinstein MM, Nobumori C, Nyrén R, Goldberg IJ, Olivecrona G, et al. (2010). GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab 12: 42-52.
67. Davies BS, Goulbourne CN, Barnes RH II, Turlo KA, Gin P, Vaughan S, Vaux DJ, Bensadoun A, Beigneux AP, Fong LG, et al. (2012). Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells. J Lipid Res 53: 2690-2697.
68. Davis RC, Wong H, Nikazy J, Wang K, Han Q, Schotz MC. (1992). Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties. J Biol Chem 267: 21499-21504.
69. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G. (2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 75: 8772-8780.
70. de Vries FP, Cole R, Dankert J, Frosch M, van Putten JP. (1998). Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol 27: 1203-1212.
71. Dichek HL, Qian K, Agrawal N. (2004). Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol 24: 1696-1702.
72. Di Marzo V. (2009). The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60: 77-84.
73. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci 99: 10819-10824.
74. Doolittle MH, Peterfy M. (2010). Mechanisms of lipase maturation. Clin Lipidol 5: 71-85.
75. Dorfman ML, Hershko C, Eisenberg S, Sagher F. (1974). Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol 110: 261-266.
76. Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, et al. (2008). Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol 28: 1866-1871.
77. Dugi KA, Dichek HL, Santamarina-Fojo S. (1995). Human hepatic and lipoprotein lipase: The loop covering the catalytic site mediates lipase substrate specificity. J BiolChem270: 25396-25401.
78. Duncan RE, Wang Y, Ahmadian M, Lu J, Sarkadi-Nagy E, Sul HS. (2010). Characterization of desnutrin functional domains: Critical residues for triacylglycerol hydrolysis in cultured cells. J Lipid Res 51: 309-317.
79. Duong M, Psaltis M, Rader DJ, Marchadier D, Barter PJ, Rye KA. (2003). Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Biochemistry 42: 13778-13785.
80. Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, Jensen MK, Rimm EB, Wang J, Rodrigues A, et al. (2009). Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 119: 1042-1050.
81. Eichmann TO, Kumari M, Haas JT, Farese RV Jr, Zimmermann R, Lass A, Zechner R. (2012). Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases. J Biol Chem 287: 41446-41457.
82. Ellong EN, Soni KG, Bui QT, Sougrat R, Golinelli-Cohen MP, Jackson CL. (2011). Interaction between the triglyceride lipase ATGL and the Arf1 activator GBF1. PLoS ONE 6: e21889.
83. Enerbäck S, Semb H, Bengtsson-Olivecrona G, Carlsson P, Hermansson M-L, Olivecrona T, Bjursell G. (1987). Molecular cloning and sequence analysis of cDNA encoding lipoprotein lipase of guinea pig. Gene 58: 1-12.
84. Farese RV Jr, Zechner R, Newgard CB, Walther TC. (2012). The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab 15: 570-573.
85. Fischer J, Lefevre C, Morava E, Mussini JM, Laforet P, Negre-Salvayre A, Lathrop M, Salvayre R. (2007). The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 39: 28-30.
86. Fletcher CM, Harrison RA, Lachmann PJ, Neuhaus D. (1994). Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure 2: 185-199.
87. Franssen R, Young SG, Peelman F, Hertecant J, Sierts JA, Schimmel AWM, Bensadoun A, Kastelein JJP, Fong LG, Dallinga-Thie GM, et al. (2010). Chylomicronemia with sow postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet 3: 169-178.
88. Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J. (1995). Normal plasma lipoproteins and fertility in genetargeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci 92: 8453-8457.
89. Fuki IV, Blanchard N, Jin W, Marchadier DH, Millar JS, Glick JM, Rader DJ. (2003). Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J Biol Chem 278: 34331-34338.
90. Gandotra S, Lim K, Girousse A, Saudek V, O'Rahilly S, Savage DB. (2011). Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator, AB-hydrolase containing 5 (ABHD5). J BiolChem286: 34998-35006.
91. Garfinkel AS, Kempner ES, Ben-Zeev O, Nikazy J, James SJ, Schotz MC. (1983). Lipoprotein lipase: Size of the functional unit determined by radiation inactivation. J Lipid Res 24: 775-780.
92. Ghosh AK, Ramakrishnan G, Rajasekharan R. (2008). YLR099C (ICT1) encodes a soluble Acyl-CoA-dependent lysophosphatidic acid acyltransferase responsible for enhanced phospholipid synthesis on organic solvent stress in Saccharomyces cerevisiae. J Biol Chem 283: 9768-9775.
93. Gin P, Beigneux AP, Davies B, Young MF, Ryan RO, Bensadoun A, Fong LG, Young SG. (2007). Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution. Biochim Biophys Acta 1771: 1464-1468.
94. Gin P, Yin L, Davies BS, Weinstein MM, Ryan RO, Bensadoun A, Fong LG, Young SG, Beigneux AP. (2008). The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J Biol Chem 284: 29554-29562.
95. Gin P, Beigneux AP, Voss C, Davies BS, Beckstead JA, Ryan RO, Bensadoun A, Fong LG, Young SG. (2011). Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. Arterioscler Thromb Vasc Biol 31: 176-182.
96. Gin P, Goulbourne CN, Adeyo O, Beigneux AP, Davies BS, Tat S, Voss CV, Bensadoun A, Fong LG, Young SG. (2012). Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1. Hum Mol Genet 21: 2961-2972.
97. Ginzinger DG, Lewis ME, Ma Y, Jones BR, Liu G, Jones SD. (1996). A mutation in the lipoprotein lipase gene Is the molecular basis of chylomicronemia in a colony of domestic cats. J Clin Invest 97: 1257-1266.
98. Ginzinger DG, Clee SM, Dallongeville J, Lewis ME, Henderson HE, Bauje E, Rogers QR, Jensen DR, Eckel RH, Dyer R, et al. (1999). Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency. Eur J Clin Invest 29: 17-26.
99. Goldberg IJ, Le NA, Paterniti JR Jr, Ginsberg HN, Lindgren FT, Brown WV. (1982). Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 70: 1184-1192.
100. Goldberg IJ, Soprano DR, Wyatt ML, Vanni TM, Kirchgessner TG, Schotz MC. (1989). Localization of lipoprotein lipase mRNA in selected rat tissues. J Lipid Res 30: 1569-1577.
101. Granneman JG, Moore HP, Granneman RL, Greenberg AS, Obin MS, Zhu Z. (2007). Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem 282: 5726-5735.
102. Granneman JG, Moore HP, Krishnamoorthy R, Rathod M. (2009). Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J Biol Chem 284: 34538-34544.
103. Granneman JG, Moore HP, Mottillo EP, Zhu Z, Zhou L. (2011). Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase. J Biol Chem 286: 5126-5135.
104. Griffon N, Budreck EC, Long CJ, Broedl UC, Marchadier DH, Glick JM, Rader DJ. (2006). Substrate specificity of lipoprotein lipase and endothelial lipase: Studies of lid chimeras. J Lipid Res 47: 1803-1811.
105. Griffon N, Jin W, Petty TJ, Millar J, Badellino KO, Saven JG, Marchadier DH, Kempner ES, Billheimer J, Glick JM, et al. (2009). Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation. J Biol Chem 284: 23322-23330.
106. Grosskopf I, Baroukh N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD. (2005). Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 25: 2573-2579.
107. Gruber A, Cornaciu I, Lass A, Schweiger M, Poeschl M, Eder C, Kumari M, Schoiswohl G, Wolinski H, Kohlwein SD, et al. (2010). The N-terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase. J Biol Chem 285: 12289-12298.
108. Guerra R, Wang J, Grundy SM, Cohen JC. (1997). A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci 94: 4532-4537.
109. Guo Y, Walther TC, Rao M, Stuurman N, Goshima G, Terayama K, Wong JS, Vale RD, Walter P, Farese RV. (2008). Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453: 657-661.
110. Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, Sattler W, Magin TM, Wagner EF, Zechner R. (2002). Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem277: 4806-4815.
111. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, et al. (2006). Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312: 734-737.
112. Haemmerle G, Moustafa T, Woelkart G, Buttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D, Kienesberger PC, Zierler K, et al. (2011). ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-a and PGC-1. Nat Med 17: 1076-1085.
113. Hahn PF. (1943). Abolishment of alimentary lipemia following injection of heparin. Science 98: 19-20.
114. Hansen HS, Rosenkilde MM, Holst JJ, Schwartz TW. (2012). GPR119 as a fat sensor. Trends Pharmacol Sci 33: 374-381.
115. Harris C, Herker E, Farese RV Jr, Ott M. (2011). Hepatitis C virus core protein decreases lipid droplet turnover: A mechanism for core-induced steatosis. J Biol Chem 286: 42615-42625.
116. Hata A, Ridinger DN, Sutherland S, Emi M, Shuhua Z, Myers RL, Ren K, Cheng T, Inoue I, Wilson DE, et al. (1993). Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain. J Biol Chem 268: 8447-8457.
117. Havel RJ. (1977). The origin and fate of chylomicrons and VLDL. Adv Exp Med Biol 82: 406-412.
118. Havel RJ. (1980). Lipoprotein biosynthesis and metabolism. Ann N Y Acad Sci 348: 16-29.
119. Havel RJ. (2010). Triglyceride-rich lipoproteins and plasma lipid transport. Arterioscler Thromb Vasc Biol 30: 9-19.
120. Havel RJ, Gordon RS Jr. (1960). Idiopathic hyperlipemia: Metabolic studies in an affected family. J Clin Invest 39: 1777-1790.
121. Hayden MR, Ma Y, Brunzell J, Henderson HE. (1991). Genetic variants affecting human lipoprotein and hepatic lipases. Curr Opin Lipidol 2: 104-109.
122. He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, Cohen JC, Hobbs HH. (2010). A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285: 6706-6715.
123. Heaton NS, Randall G. (2010). Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8: 422-432.
124. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. (2010). Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci 107: 17345-17350.
125. Heckmann BL, Zhang X, Xie X, Liu J. (2013). The G0/G1 switch gene 2 (G0S2): Regulating metabolism and beyond. Biochim Biophys Acta 1831: 276-281.
126. Hegele RA, Little JA, Connelly PW. (1991). Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem Biophys Res Commun 179: 78-84.
127. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW. (1993). Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13: 720-728.
128. Henderson HE, Hassan F, Marais D, Hayden MR. (1996). A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase. Biochem Biophys Res Commun 227: 189-194.
129. Henderson H, Leisegang F, Hassan F, Hayden M, Marais D. (1998). A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis. Clin Chim Acta 269: 1-12.
130. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, Farese RV Jr, Ott M. (2010). Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16: 1295-1298.
131. Hill JS, Davis RC, Yang D, Schotz MC, Wong H. (1997). Hepatic lipase: High-level expression and subunit structure determination. Methods Enzymol 284: 232-246.
132. Hill JS, Yang D, Nikazy J, Curtiss LK, Sparrow JT, Wong H. (1998). Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding. J Biol Chem 273: 30979-30984.
133. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. (2008). Triglyceride deposit cardiomyovasculopathy. N Engl J Med 359: 2396-2398.
134. Holm C. (2003). Molecular mechanisms regulating hormonesensitive lipase and lipolysis. Biochem Soc Trans 31: 1120-1124.
135. Holm C, Osterlund T, Laurell H, Contreras JA. (2000). Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 20: 365-393.
136. Holmes RS, Cox LA. (2012). Comparative studies of glycosylphosphatidylinositol-anchored high-density lipoproteinbinding protein 1: Evidence for a eutherian mammalian origin for the GPIHBP1 gene from an LY6-like gene. 3 Biotech 2: 37-52.
137. Holmes RS, Vandeberg JL, Cox LA. (2011a). Comparative studies of vertebrate lipoprotein lipase: A key enzyme of very low density lipoprotein metabolism. Comp Biochem Physiol Part D Genomics Proteomics 6: 224-234.
138. Holmes RS, Vandeberg JL, Cox LA. (2011b). Vertebrate endothelial lipase: Comparative studies of an ancient gene and protein in vertebrate evolution. Genetica 139: 291-304.
139. Holmes RS, Vandeberg JL, Cox LA. (2011c). Vertebrate hepatic lipase genes and proteins: A review supported by bioinformatic studies. Open access bioinformatics 2011: 85-95.
140. Hoogewerf AJ, Cisar LA, Evans DC, Bensadoun A. (1991). Effect of chlorate on the sulfation of lipoprotein lipase and heparan sulfate proteoglycans. Sulfation of heparan sulfate proteoglycans affects lipoprotein lipase degradation. J Biol Chem 266: 16564-16571.
141. Hoy AJ, Bruce CR, Turpin SM, Morris AJ, Febbraio MA, Watt MJ. (2011). Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation. Endocrinology 152: 48-58.
142. Huang Y, Cohen JC, Hobbs HH. (2011). Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem 286: 37085-37093.
143. Igal RA, Rhoads JM, Coleman RA. (1997). Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr 25: 541-547.
144. Inadera H, Hibino A, Kobayashi J, Kanzaki T, Shirai K, Yukawa S, Saito Y, Yoshida S. (1993). A missense mutation (Trp 26/Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun 193: 1174-1183.
145. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. (2008). Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 8: 77-83.
146. Ioka RX, KangM-J, Kamiyama S, Kim D-H, Magoori K, Kamataki A, Ito Y, Takei YA, Sasaki M, Suzuki T, et al. (2003). Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoproteinbinding protein, GPI-HBP1. J Biol Chem278: 7344-7349.
147. Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, Cooper AD, Quertermous T. (2003). Endothelial lipase is a major determinant of HDL level. J Clin Invest 111: 347-355.
148. Iverius PH, Ostlund-Lindqvist AM. (1976). Lipoprotein lipase from bovine milk. Isolation procedure, chemical characterization, and molecular weight analysis. J Biol Chem 251: 7791-7795.
149. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. (1999). A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 21: 424-428.
150. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. (2004). Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279: 48968-48975.
151. Jin W, Millar JS, Broedl U, Glick JM, Rader DJ. (2003a). Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest 111: 357-362.
152. Jin W, Sun GS, Marchadier D, Octtaviani E, Glick JM, Rader DJ. (2003b). Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res 92: 644-650.
153. Jin W, Wang X, Millar JS, Quertermous T, Rothblat GH, Glick JM, Rader DJ. (2007). Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6: 129-136.
154. Jocken JW, Blaak EE. (2008). Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav 94: 219-230.
155. Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, et al. (2012). A PPARg-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485: 391-394.
156. Jordans GH. (1953). The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB.). Acta Med Scand 145: 419-423.
157. Jung KM, Clapper JR, Fu J, D'Agostino G, Guijarro A, Thongkham D, Avanesian A, Astarita G, DiPatrizio NV, Frontini A, et al. (2012). 2-Arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab 15: 299-310.
158. Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R, Jansson M, Smedby KE, Hjalgrim H, Jurlander J, et al. (2011). LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 96: 1153-1160.
159. Keiper T, Schneider JG, Dugi KA. (2001). Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability. J Lipid Res 42: 1180-1186.
160. Kienesberger PC, Lee D, Pulinilkunnil T, Brenner DS, Cai L, Magnes C, Koefeler HC, Streith IE, Rechberger GN, Haemmerle G, et al. (2009a). Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem284: 30218-30229.
161. Kienesberger PC, Oberer M, Lass A, Zechner R. (2009b). Mammalian patatin domain containing proteins: A family with diverse lipolytic activities involved in multiple biological functions. J Lipid Res 50: S63-S68.
162. Kinnunen PKJ, Jackson RL, Smith LC, Gotto AM Jr, Sparrow JT. (1977). Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci 74: 4848-4851.
163. Kirchgessner TG, Svenson KL, Lusis AJ, Schotz MC. (1987). The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. J Biol Chem 262: 8463-8466.
164. Klinger MM, Margolis RU, Margolis RK. (1985). Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipaseagarose. J Biol Chem 260: 4082-4090.
165. Kobayashi Y, Nakajima T, Inoue I. (2002). Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain. Eur J Biochem 269: 4701-4710.
166. Kobayashi K, Inoguchi T, Maeda Y, Nakashima N, Kuwano A, Eto E, Ueno N, Sasaki S, Sawada F, Fujii M, et al. (2008). The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab 93: 2877-2884.
167. Kolditz CI, Langin D. (2010). Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care 13: 377-381.
168. Komaromy MC, Schotz MC. (1987). Cloning of rat hepatic lipase cDNA: Evidence for a lipase gene family. Proc Natl Acad Sci 84: 1526-1530.
169. Kompiang IP, Bensadoun A, Yang MW. (1976). Effect of an antilipoprotein lipase serum on plasma triglyceride removal. J Lipid Res 17: 498-505.
170. Korn ED. (1955a). Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem 215: 1-14.
171. Korn ED. (1955b). Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J Biol Chem 215: 15-26.
172. Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Fraser CC, Yang DD, et al. (2005). Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: Regulation of triglyceride metabolism. Endocrinology 146: 4943-4950.
173. Kraemer FB, Shen WJ, Natu V, Patel S, Osuga J, Ishibashi S, Azhar S. (2002). Adrenal neutral cholesteryl ester hydrolase: Identification, subcellular distribution, and sex differences. Endocrinology 143: 801-806.
174. Krauss RM, Windmueller HG, Levy RI, Fredrickson DS. (1973). Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. J Lipid Res 14: 286-295.
175. Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM, et al. (2011). Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Mol Cancer Ther 10: 427-436.
176. Kumari M, Schoiswohl G, Chitraju C, Paar M, Cornaciu I, Rangrez AY, Wongsiriroj N, Nagy HM, Ivanova PT, Scott SA, et al. (2012). Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab 15: 691-702.
177. Kuramoto K, Okamura T, Yamaguchi T, Nakamura TY, Wakabayashi S, Morinaga H, Nomura M, Yanase T, Otsu K, Usuda N, et al. (2012). Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation. J Biol Chem 287: 23852-23863.
178. Kurat CF, Natter K, Petschnigg J, Wolinski H, Scheuringer K, Scholz H, Zimmermann R, Leber R, Zechner R, Kohlwein SD. (2006). Obese yeast: Triglyceride lipolysis is functionally conserved from mammals to yeast. J Biol Chem 281: 491-500.
179. Labar G, Bauvois C, Borel F, Ferrer JL, Wouters J, Lambert DM. (2010). Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. ChemBio-Chem 11: 218-227.
180. Lafontan M, Langin D. (2009). Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48: 275-297.
181. Lam CW, Yuen YP, Cheng WF, Chan YW, Tong SF. (2006). Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome. Clinica Chim Acta 364: 256-259.
182. Langner CA, Birkenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. (1989). The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem 264: 7994-8003.
183. Lass A, Zimmermann R, Haemmerle G, Riederer M, Schoiswohl G, Schweiger M, Kienesberger P, Strauss JG, Gorkiewicz G, Zechner R. (2006). Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 3: 309-319.
184. Lass A, Zimmermann R, Oberer M, Zechner R. (2011). Lipolysis-a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 50: 14-27.
185. Laurin NN, Wang SP, Mitchell GA. (2000). The hormone-sensitive lipase gene is transcribed from at least five alternative first exons in mouse adipose tissue. Mamm Genome 11: 972-978.
186. Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, Lakhdar H, Wollenberg A, Verret JL, Weissenbach J, et al. (2001). Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 69: 1002-1012.
187. Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH. (2012). Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest 122: 4130-4144.
188. Listenberger LL, Ostermeyer-Fay AG, Goldberg EB, Brown WJ, Brown DA. (2007). Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover. J Lipid Res 48: 2751-2761.
189. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavon FJ, Serrano AM, Selley DE, Parsons LH, et al. (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37-44.
190. Lookene A, Groot NB, Kastelein JJ, Olivecrona G, Bruin T. (1997a). Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties. J Biol Chem 272: 766-772.
191. Lookene A, Savonen R, Olivecrona G. (1997b). Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique. Biochemistry 36: 5267-5275.
192. Lookene A, Nielsen MS, Gliemann J, Olivecrona G. (2000). Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins. Biochem Biophys Res Commun 271: 15-21.
193. Ma Y, Henderson HE, Liu MS, Zhang H, Forsythe IJ, Clarke-Lewis I, Hayden MR, Brunzell JD. (1994a). Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase. J Lipid Res 35: 2049-2059.
194. Ma Y, Ooi TC, Liu MS, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR. (1994b). High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: Possible association with apolipoprotein E2 isoform. J Lipid Res 35: 1066-1075.
195. Maillard P, Walic M, Meuleman P, Roohvand F, Huby T, Le Goff W, Leroux-Roels G, Pecheur EI, Budkowska A. (2011). Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry. PLoS ONE 6: e26637.
196. Mailly F, Palmen J, Muller DP, Gibbs T, Lloyd J, Brunzell J, Durrington P, Mitropoulos K, Betteridge J, Watts G, et al. (1997). Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy. Hum Mutat 10: 465-473.
197. Maloum K, Settegrana C, Chapiro E, Cazin B, Lepretre S, Delmer A, Leporrier M, Dreyfus B, Tournilhac O, Mahe B, et al. (2009). IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Ann Hematol 88: 1215-1221.
198. Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, Roos G, Olivecrona G, Rosenquist R. (2010). Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res 34: 301-306.
199. Martin GA, Busch SJ, Meredith GD, Cardin AD, Blankenship DT, Mao SJT, Rechtin AE, Woods CW, Racke MM, Schafer MP, et al. (1988). Isolation and cDNA sequence of human postheparin plasma hepatic triglyceride lipase. J Biol Chem 263: 10907-10914.
200. Mason RR, Meex RC, Lee-Young R, Canny BJ, Watt MJ. (2012). Phosphorylation of adipose triglyceride lipase Ser(404) is not related to 59-AMPK activation during moderate-intensity exercise in humans. Am J Physiol Endocrinol Metab 303: E534-E541.
201. Menendez JA. (2009). Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives. Biochim Biophys Acta 1801: 381-391.
202. Merkel M, Kako Y, Radner H, Cho IS, Ramasamy R, Brunzell JD, Goldberg IJ, Breslow JL. (1998). Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci 95: 13841-13846.
203. Merkel M, Eckel RH, Goldberg IJ. (2002). Lipoprotein lipase: Genetics, lipid uptake, and regulation. J Lipid Res 43: 1997-2006.
204. Miesenbock G, Holzl B, Foger B, Brandstatter E, Paulweber B, Sandhofer F, Patsch JR. (1993). Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 91: 448-455.
205. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. (2007). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 1089-1097.
206. Montero-Moran G, Caviglia JM, McMahon D, Rothenberg A, Subramanian V, Xu Z, Lara-Gonzalez S, Storch J, Carman GM, Brasaemle DL. (2009). CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase. J Lipid Res 51: 709-719.
207. Morley N, Kuksis A. (1972). Positional specificity of lipoprotein lipase. J Biol Chem 247: 6389-6393.
208. Mottillo EP, Bloch AE, Leff T, Granneman JG. (2012). Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) a and d in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem 287: 25038-25048.
209. Mulder M, Lombardi P, Jansen H, van Berkel TJ, Frants RR, Havekes LM. (1993). Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J Biol Chem 268: 9369-9375.
210. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, et al. (2003). Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278: 36380-36388.
211. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. (2008). Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26: 1179-1186.
212. Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, Garimella KV, Fisher S, Abreu J, Barry AJ, et al. (2010). Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 363: 2220-2227.
213. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, et al. (2010). Genome-wide association study of advanced agerelated macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci 107: 7395-7400.
214. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, Fornes P, Tailleux L, Barrios Payan JA, Pivert E, Bordat Y, Aguilar D, Prevost MC, et al. (2006). Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE 1: e43.
215. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140: 49-61.
216. Nomura DK, Lombardi DP, Chang JW, Niessen S, Ward AM, Long JZ, Hoover HH, Cravatt BF. (2011). Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem Biol 18: 846-856.
217. Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, Ward AM, Hahn YK, Lichtman AH, Conti B, et al. (2012). Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334: 809-813.
218. Nordestgaard BG, Zilversmit DB. (1988). Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res 29: 1491-1500.
219. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. (1997). Heterozygous lipoprotein lipase deficiency: Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 96: 1737-1744.
220. Oberer M, Boeszoermenyi A, Nagy HM, Zechner R. (2011). Recent insights into the structure and function of comparative gene identification-58. Curr Opin Lipidol 22: 149-158.
221. Obrowsky S, Chandak PG, Patankar JV, Pfeifer T, Povoden S, Schreiber R, Haemmerle G, Levak-Frank S, Kratky D. (2012). Cholesteryl ester accumulation and accelerated cholesterol absorption in intestine-specific hormone sensitive lipasenull mice. Biochim Biophys Acta 1821: 1406-1414.
222. Obunike JC, Lutz EP, Li Z, Paka L, Katopodis T, Strickland DK, Kozarsky KF, Pillarisetti S, Goldberg IJ. (2001). Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J Biol Chem 276: 8934-8941.
223. O'Connell DP, LeBlanc DF, Cromley D, Billheimer J, Rader DJ, Bachovchin WW. (2012). Design and synthesis of boronic acid inhibitors of endothelial lipase. Bioorg Med Chem Lett 22: 1397-1401.
224. Olafsen T, Young SG, Davies BS, Beigneux AP, Kenanova VE, Voss C, Young G, Wong KP, Barnes RH II, Tu Y, et al. (2010). Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning. J Biol Chem 285: 39239-39248.
225. Olivecrona G, Beisiegel U. (1997). Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons. Arterioscler Thromb Vasc Biol 17: 1545-1549.
226. Olivecrona T, Bengtsson-Olivecrona G, Chernick SS, Scow RO. (1986). Effect of combined lipase deficiency (cld/cld) on hepatic and lipoprotein lipase activities in liver and plasma of newborn mice. Biochim Biophys Acta 876: 243-248.
227. Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden MR, Gin P, Davies BS, Weinstein MM, Fong LG, et al. (2010). Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res 51: 1535-1545.
228. Ong KT, Mashek MT, Bu SY, Greenberg AS, Mashek DG. (2011). Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 53: 116-126.
229. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri F, Yahagi N, Kraemer FB, Tsutsumi O, et al. (2000). Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci 97: 787-792.
230. Pagnon J, Matzaris M, Stark R, Meex RC, Macaulay SL, Brown W, O'Brien PE, Tiganis T, Watt MJ. (2012). Identification and functional characterization of protein kinase A phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase. Endocrinology 153: 4278-4289.
231. Pappan KL, Pan Z, Kwon G, Marshall CA, Coleman T, Goldberg IJ, McDaniel ML, Semenkovich CF. (2005). Pancreatic b-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. J Biol Chem 280: 9023-9029.
232. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI, et al. (2005). Hormonesensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol Endocrinol Metab 289: E30-E39.
233. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart J-C, Krauss RM, Rubin EM. (2001). An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173.
234. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. (2002). Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038.
235. Peterfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR, Frost PH, Kane JP, Malloy MJ, Reue K, et al. (2007). Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 39: 1483-1487.
236. Peyot ML, Guay C, Latour MG, Lamontagne J, Lussier R, Pineda M, Ruderman NB, Haemmerle G, Zechner R, Joly E, et al. (2009). Adipose triglyceride lipase is implicated in fueland non-fuel-stimulated insulin secretion. J Biol Chem284: 16848-16859.
237. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, et al. (2008). A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322: 1702-1705.
238. Previato L, Guardamagna O, Brunzell JD, Santamarina-Fojo S, Brewer HB Jr. (1992). A novel missense mutation in the C-terminal domain of lipoprotein lipase leads to enzyme inactivation. Circulation 86: 1-608.
239. Quiroga AD, Lehner R. (2012). Liver triacylglycerol lipases. Biochim Biophys Acta 1821: 762-769.
240. Radner FP, Streith IE, Schoiswohl G, Schweiger M, Kumari M, Eichmann TO, Rechberger G, Koefeler HC, Eder S, Schauer S, et al. (2010). Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 285: 7300-7311.
241. Rajakumari S, Daum G. (2010). Janus-faced enzymes yeast Tgl3p and Tgl5p catalyze lipase and acyltransferase reactions. Mol Biol Cell 21: 501-510.
242. Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, Blaner WS, Goldberg IJ, Schwabe RF, Chua SC Jr, Huang LS. (2008). Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem 283: 13087-13099.
243. Reina M, Brunzell JD, Deeb SS. (1992). Molecular basis of familial chylomicronemia: Mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res 33: 1823-1832.
244. Rios JJ, Shastry S, Jasso J, Hauser N, Garg A, Bensadoun A, Cohen JC, Hobbs HH. (2011). Deletion of GPIHBP1 causing severe chylomicronemia. J Inherit Metab Dis 35: 531-540.
245. Rodriguez JA, Ben Ali Y, Abdelkafi S, Mendoza LD, Leclaire J, Fotiadu F, Buono G, Carriere F, Abousalham A. (2010). In vitro stereoselective hydrolysis of diacylglycerols by hormonesensitive lipase. Biochim Biophys Acta 1801: 77-83.
246. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M. (2001). A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: A study in hormone-sensitive lipasedeficient mice. Diabetes 50: 1970-1975.
247. Rogalska E, Cudrey C, Ferrato F, Verger R. (1993). Stereoselective hydrolysis of triglycerides by animal and microbial lipases. Chirality 5: 24-30.
248. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. (2007). Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39: 513-516.
249. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. (2008). Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
250. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC. (2009). Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 119: 70-79.
251. Russell L, Forsdyke DR. (1991). A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 10: 581-591.
252. Rydel TJ, Williams JM, Krieger E, Moshiri F, Stallings WC, Brown SM, Pershing JC, Purcell JP, Alibhai MF. (2003). The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad. Biochemistry 42: 6696-6708.
253. Ryden M, Agustsson T, Laurencikiene J, Britton T, Sjolin E, Isaksson B, Permert J, Arner P. (2008). Lipolysis-not inflammation, cell death, or lipogenesis-is involved in adipose tissue loss in cancer cachexia. Cancer 113: 1695-1704.
254. Sanan DA, Fan J, Bensadoun A, Taylor JM. (1997). Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res 38: 1002-1013.
255. Sanchez-Pinera P, Micol V, Corbalan-Garcia S, Gomez-Fernandez JC. (1999). A comparative study of the activation of protein kinase C a by different diacylglycerol isomers. Biochem J 337: 387-395.
256. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, Wagner E, Nong Z. (2004). Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 24: 1750-1754.
257. Sapiro JM, Mashek MT, Greenberg AS, Mashek DG. (2009). Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor a activity. J Lipid Res 50: 1621-1629.
258. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, et al. (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119.
259. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R. (2006). Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281: 40236-40241.
260. Schweiger M, Schoiswohl G, Lass A, Radner FP, Haemmerle G, Malli R, Graier W, Cornaciu I, Oberer M, Salvayre R, et al. (2008). The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem 283: 17211-17220.
261. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. (2009). Neutral lipid storage disease: Genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab 297: E289-E296.
262. Schweiger M, Paar M, Eder C, Brandis J, Moser E, Gorkiewicz G, Grond S, Radner FP, Cerk I, Cornaciu I, et al. (2012). G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase. J Lipid Res 53: 2307-2317.
263. Sekiya M, Osuga J, Yahagi N, Okazaki H, Tamura Y, Igarashi M, Takase S, Harada K, Okazaki S, Iizuka Y, et al. (2008). Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. J Lipid Res 49: 1829-1838.
264. Semenkovich CF, Luo CC, Nakanishi MK, Chen SH, Smith LC, Chan L. (1990). In vitro expression and site-specific mutagenesis of the cloned human lipoprotein lipase gene. Potential N-linked glycosylation site asparagine 43 is important for both enzyme activity and secretion. J Biol Chem 265: 5429-5433.
265. Sendak RA, Melford K, Kao A, Bensadoun A. (1998). Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: New evidence for a carboxyl-terminal heparin-binding domain. J Lipid Res 39: 633-646.
266. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, Santini L, Biolchi A, Seib KL, Giuliani MM, et al. (2010). Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci 107: 3770-3775.
267. Shen Y, Lookene A, Zhang L, Olivecrona G. (2010). Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase. J Biol Chem 285: 7484-7492.
268. Shen WJ, Yu Z, Patel S, Jue D, Liu LF, Kraemer FB. (2011). Hormone-sensitive lipase modulates adipose metabolism through PPARg. Biochim Biophys Acta 1811: 9-16.
269. Shimada K, Gill PJ, Silbert JE, Douglas WH, Fanburg BL. (1981). Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J Clin Invest 68: 995-1002.
270. Shimizu Y, Hishiki T, Sugiyama K, Ogawa K, Funami K, Kato A, Ohsaki Y, Fujimoto T, Takaku H, Shimotohno K. (2010). Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins. Virology 407: 152-159.
271. Soni KG, Mardones GA, Sougrat R, Smirnova E, Jackson CL, Bonifacino JS. (2009). Coatomer-dependent protein delivery to lipid droplets. J Cell Sci 122: 1834-1841.
272. Spindler KR, Welton AR, Lim ES, Duvvuru S, Althaus IW, Imperiale JE, Daoud AI, Chesler EJ. (2010). The major locus for mouse adenovirus susceptibility maps to genes of the hematopoietic cell surface-expressed LY6 family. J Immunol 184: 3055-3062.
273. Steiner G, Myher JJ, Kuksis A. (1985). Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia. Am J Clin Nutr 41: 121-128.
274. Strauss JG, Frank S, Kratky D, Hammerle G, Hrzenjak A, Knipping G, von Eckardstein A, Kostner GM, Zechner R. (2001). Adenovirus-mediated rescue of lipoprotein lipasedeficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem 276: 36083-36090.
275. Strom K, Hansson O, Lucas S, Nevsten P, Fernandez C, Klint C, Moverare-Skrtic S, Sundler F, Ohlsson C, Holm C. (2008). Attainment of brown adipocyte features in white adipocytes of hormone-sensitive lipase null mice. PLoS ONE 3: e1793.
276. Strom K, Gundersen TE, Hansson O, Lucas S, Fernandez C, Blomhoff R, Holm C. (2009). Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: Evidence from mice lacking HSL. FASEB J 23: 2307-2316.
277. Sukonina V, Lookene A, Olivecrona T, Olivecrona G. (2006). Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci 103: 17450-17455.
278. Sun Z, Lazar MA. (2013). Dissociating fatty liver and diabetes. Trends Endocrinol Metab 24: 4-12.
279. Sun H, Jiang L, Luo X, Jin W, He Q, An J, Lui K, Shi J, Rong R, Su W, et al. (2013). Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer. Oncogene 32: 234-241.
280. Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Peterfy M, Kastelein JJ, et al. (2012). Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med 272: 185-196.
281. Taschler U, Radner FP, Heier C, Schreiber R, Schweiger M, Schoiswohl G, Preiss-Landl K, Jaeger D, Reiter B, Koefeler HC, et al. (2011). Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem 286: 17467-17477.
282. Thomssen R, Bonk S. (2002). Virolytic action of lipoprotein lipase on hepatitis C virus in human sera. Med Microbiol Immunol (Berl) 191: 17-24.
283. Tornqvist H, Belfrage P. (1976). Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem 251: 813-819.
284. Turpin SM, Hoy AJ, Brown RD, Rudaz CG, Honeyman J, Matzaris M, Watt MJ. (2011). Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 54: 146-156.
285. Tuzgol S, Bijvoet SM, Bruin T, Kastelein JJ, Hayden MR. (1994). Apolipoprotein CII-Padova (Tyr37/stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana. J Med Genet 31: 622-626.
286. Uchida Y, Cho Y, Moradian S, Kim J, Nakajima K, Crumrine D, Park K, Ujihara M, Akiyama M, Shimizu H, et al. (2010). Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. J Invest Dermatol 130: 2497-2499.
287. Ullrich NF, Purnell JQ, Brunzell JD. (2001). Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency. J Investig Med 49: 273-275.
288. Vallet-Erdtmann V, Tavernier G, Contreras JA, Mairal A, Rieu C, Touzalin AM, Holm C, Jegou B, Langin D. (2004). The testicular form of hormone-sensitive lipase HSLtes confers rescue of male infertility in HSL-deficient mice. J Biol Chem 279: 42875-42880.
289. Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B, Philippe J. (2007). Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 53: 204-212.
290. Vander Heiden MG, Cantley LC, Thompson CB. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033.
291. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. (2009). Cold-activated brown adipose tissue in healthy men. N Engl J Med 360: 1500-1508.
292. Vatannejad A, Khodadadi I, Amiri I, Vaisi-Raygani A, Ghorbani M, Tavilani H. (2011). Genetic variation of hormone sensitive lipase and male infertility. Syst Biol Reprod Med 57: 288-291.
293. Vaughan M, Berger JE, Steinberg D. (1964). Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. J Biol Chem 239: 401-409.
294. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. (1998). Hepatic lipase activity is lower in African American men than in white American men: Effects of 59 flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 39: 228-232.
295. Vilaro S, Camps L, Reina M, Perez-Clausell J, Llobera M, Olivecrona T. (1990). Localization of lipoprotein lipase to discrete areas of the guinea pig brain. Brain Res 506: 249-253.
296. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. (2004). Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: Ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279: 47066-47075.
297. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S, et al. (2009). Functional brown adipose tissue in healthy adults. N Engl J Med 360: 1518-1525.
298. Vogt AM, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M. (2003). Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1a domain of PfEMP1. Blood 101: 2405-2411.
299. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Holm H, Ding EL, Johnson T, et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: A Mendelian randomisation study. Lancet 380: 572-580.
300. Voshol PJ, Haemmerle G, Ouwens DM, Zimmermann R, Zechner R, Teusink B, Maassen JA, Havekes LM, Romijn JA. (2003). Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144: 3456-3462.
301. Voss CV, Davies BS, Tat S, Gin P, Fong LG, Pelletier C, Mottler CD, Bensadoun A, Beigneux AP, Young SG. (2011). Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1. Proc Natl Acad Sci 108: 7980-7984.
302. Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF, Pan L, Oligny L, Mitchell GA. (2001). The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 9: 119-128.
303. Wang S, Soni KG, Semache M, Casavant S, Fortier M, Pan L, Mitchell GA. (2008). Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab 95: 117-126.
304. Wang H, Astarita G, Taussig MD, Bharadwaj KG, DiPatrizio NV, Nave KA, Piomelli D, Goldberg IJ, Eckel RH. (2011a). Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab 13: 105-113.
305. Wang H, Bell M, Sreenevasan U, Hu H, Liu J, Dalen K, Londos C, Yamaguchi T, Rizzo MA, Coleman R, et al. (2011b). Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem 286: 15707-15715.
306. Weinstein MM, Yin L, Beigneux AP, Davies BS, Gin P, Estrada K, Melford K, Bishop JR, Esko JD, Dallinga-Thie GM, et al. (2008). Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem 283: 34511-34518.
307. Weinstein MM, Yin L, Tu Y, Wang X, Wu X, Castellani LW, Walzem RL, Lusis AJ, Fong LG, Beigneux AP, et al. (2010). Chylomicronemia elicits atherosclerosis in mice-brief report. Arterioscler Thromb Vasc Biol 30: 20-23.
308. Weinstein MM, Goulbourne CN, Davies BS, Tu Y, Barnes RH II, Watkins SM, Davis R, Reue K, Tontonoz P, Beigneux AP, et al. (2012). Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient mice. Arterioscler Thromb Vasc Biol 32: 230-235.
309. Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL. (1995). Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555-2568.
310. Whitehead RH. (1909). A note on the absorption of fat. Am J Physiol 24: 294-296.
311. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. (2006). Characterization of the human patatin-like phospholipase family. J Lipid Res 47: 1940-1949.
312. Wion KL, Kirchgessner TG, Lusis AJ, Schotz MC, Lawn RM. (1987). Human lipoprotein lipase complementary DNA sequence. Science 235: 1638-1641.
313. Wong H, Davis RC, Thuren T, Goers JW, Nikazy J, Waite M, Schotz MC. (1994). Lipoprotein lipase domain function. J Biol Chem 269: 10319-10323.
314. Wong H, Yang D, Hill JS, Davis RC, Nikazy J, Schotz MC. (1997). A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase. Proc Natl Acad Sci 94: 5594-5598.
315. Wu JW, Wang SP, Alvarez F, Casavant S, Gauthier N, Abed L, Soni KG, Yang G, Mitchell GA. (2011). Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 54: 122-132.
316. Yang X, Lu X, Liu J. (2010a). Identification of a novel splicing isoform of murine CGI-58. FEBS Lett 584: 903-910.
317. Yang X, Lu X, Lombes M, Rha GB, Chi YI, Guerin TM, Smart EJ, Liu J. (2010b). The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 11: 194-205.
318. Yasuda T, Hirata K, Ishida T, Kojima Y, Tanaka H, Okada T, Quertermous T, Yokoyama M. (2007). Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. J Atheroscler Thromb 14: 192-201.
319. Yasuda T, Ishida T, Rader DJ. (2010). Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 74: 2263-2270.
320. Ye L, Zhang B, Seviour EG, Tao KX, Liu XH, Ling Y, Chen JY, Wang GB. (2011). Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer. Cancer Lett 307: 6-17.
321. Yin W, Romeo S, Chang S, Grishin NV, Hobbs HH, Cohen JC. (2009). Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 284: 13213-13222.
322. Yoshida K, Shimizugawa T, Ono M, Furukawa H. (2002). Angiopoietin-like protein 4 is a potent hyperlipidemiainducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43: 1770-1772.
323. Young SG, Davies BS, Voss CV, Gin P, Weinstein MM, Tontonoz P, Reue K, Bensadoun A, Fong LG, Beigneux AP. (2011). GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J Lipid Res 52: 1869-1884.
324. Yuan C, Rieke CJ, Rimon G, Wingerd BA, Smith WL. (2006). Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci 103: 6142-6147.
325. Yuan C, Sidhu RS, Kuklev DV, Kado Y, Wada M, Song I, Smith WL. (2009). Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J Biol Chem 284: 10046-10055.
326. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. (2009). Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 50: 3-21.
327. Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ. (2001). Regulation of lipoprotein lipase by the oxysterol receptors, LXRa and LXRb. J Biol Chem 276: 43018-43024.
328. Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X, Fan J, Ross C, Karasinska J, Hayden MR, et al. (2008). Spontaneous atherosclerosis in aged lipoproteinl lipase deficient mice with wevere hypertriglyceridemia on a normal chow diet. Circ Res 102: 250-256.
329. Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. (2002). Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci 99: 3932-3937.
330. Zimmermann R, Haemmerle G, Wagner EM, Strauss JG, Kratky D, Zechner R. (2003). Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormonesensitive lipase-deficient white adipose tissue. J Lipid Res 44: 2089-2099.
331. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, et al. (2004). Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306: 1383-1386.
332. Ziouzenkova O, Perrey S, Asatryan L, Hwang J, MacNaul KL, Moller DE, Rader DJ, Sevanian A, Zechner R, Hoefler G, et al. (2003). Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci 100: 2730-2735.